ArisGlobal Wins Growing Client Base for Drug Safety and Risk Management Platform agBalance
Companies Turn to Signal Detection and Risk Management Solution for Seamless Integration, End-to-End Safety Life Cycle Management, and Ease-of-Use
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
Companies Turn to Signal Detection and Risk Management Solution for Seamless Integration, End-to-End Safety Life Cycle Management, and Ease-of-Use
Pay-As-You-Grow Service Offering Delivers Competitive Edge to CROs looking for ...
Dr. Bahadursingh joined ArisGlobal in September, 2016, and brings more than 17 years of drug safety and risk management experience to ArisGlobal’s Safety and Pharmacovigilance business unit. The following is an English translation of a feature by Japan’s Yakuji Nippo.
REGULATORY COMPLIANCE, INCREASED PRODUCTIVITY, QUALITY MANAGEMENT, AND LOWER TOTAL COST ...
September 23, 2016 – ArisGlobal®, a leading provider of integrated, ...
New Life Sciences Solution Supports, Enables and Simplifies Compliance Across ...
ArisGlobal®, a leading provider of cloud-based software solutions for life ...
Dr. Vivek Ahuja, George Phillips and Stephen Schmidt Join the ...
CHICAGO, IL.  APRIL 10th, 2016: ArisGlobal®, a leading provider of ...
ArisGlobal continues to support Merck KGaA, the biopharmaceutical business of ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved